(Q44139042)

30 November 2017

0 references

NASH, from diagnosis to treatment: Where do we stand? (English)

1 reference

30 November 2017

Stephen A Harrison

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

8 October 2015

1 reference

30 November 2017

1 reference

30 November 2017

volume

62

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

1652-1655

1 reference

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

30 November 2017

cites work

1 reference

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.

21 January 2018

1 reference

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease

21 January 2018

1 reference

Weight loss in nonalcoholic Fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.28275

1 reference

30 November 2017

1 reference